Vitamin B News and Research

Latest Vitamin B News and Research

UCSF to create first implantable device for patients with kidney failure

A $750,000 gift from the John and Marcia Goldman Foundation is spurring a UCSF-led effort to create the first implantable artificial kidney for patients with kidney failure.

3 Oct 2012

Five researchers receive IOF Young Investigator Awards

Five researchers were presented with 'IOF Young Investigator Awards' at the International Osteoporosis Foundation (IOF) Regionals - 2nd Middle East & Africa Osteoporosis Meeting and the 6th Pan Arab Osteoporosis Congress PAOC'6 on September 30, 2012.

2 Oct 2012

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC).

1 Oct 2012

Autism Speaks announces new round of research grants

Autism Speaks, the world's leading autism science and advocacy organization, today announced the awarding of new research grants totaling nearly $5 million. "Autism Speaks is committed to continuing our research which has tremendous potential to increase our understanding of autism and addressing the needs of individuals with autism," said Autism Speaks Co-founder Bob Wright, "and we are grateful to the donors who make this research possible."

29 Sep 2012

Global Strategy for Women's and Children's Health receives $20 billion in new money

The Global Strategy for Women's and Children's Health has received about $20 billion in new money, according to a new report from The Partnership for Maternal, Newborn & Child Health (PMNCH).

28 Sep 2012

Sunshine vitamin affects cardiac outcomes

Vitamin D deficiency could increase the risk for ischemic heart disease, myocardial infarction, and early death, researchers suggest.

27 Sep 2012

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).

27 Sep 2012

Comprehensive prenatal care can decrease rates of low birth weights

Comprehensive prenatal care can decrease the rate of low birth weights, according to a study led by Dr. Yasmin Neggers, a University of Alabama researcher and professor of human nutrition and hospitality management.

25 Sep 2012

Low levels of vitamin D associated with higher risk of heart attack and early death

New research from the University of Copenhagen and Copenhagen University Hospital shows that low levels of vitamin D are associated with a markedly higher risk of heart attack and early death. The study involved more than 10,000 Danes and has been published in the well-reputed American journal Arteriosclerosis, Thrombosis and Vascular Biology.

24 Sep 2012

New technique allows cells to make terpenes

Scientists at The Scripps Research Institute have shown how to synthesize in the laboratory an important set of natural compounds known as terpenes. The largest class of chemicals made by living organisms, terpenes are made within cells by some of the most complex chemical reactions found in biology.

24 Sep 2012

Vitamin D deficiency affects more Australians than previously thought

September marks the start of spring but new research reveals it is also the month when Australians’ vitamin D levels are at their lowest ebb.

24 Sep 2012

Maternal choline intake could essentially change fetal genetic expression into adulthood

Just as women are advised to get plenty of folic acid around the time of conception and throughout early pregnancy, new research suggests another very similar nutrient may one day deserve a spot on the obstetrician's list of recommendations.

24 Sep 2012

Child mortality rate nearly halved in Niger since 1998, analysis shows

"Niger has nearly halved the death rate of children below five years old since 1998, a significant drop highlighting the benefits of free universal health care for children and pregnant women as well as increased donor funding for health," according to a analysis published in the Lancet, IRIN reports.

21 Sep 2012

EMA CHMP adopts positive opinion for ELIQUIS to prevent stroke, systemic embolism in NVAF patients

Bristol-Myers Squibb and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending that ELIQUIS (apixaban) be granted approval for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) and one or more risk factors for stroke.

21 Sep 2012

Researchers use nanoparticles to deliver drugs to mitochondria within cells

Nanoparticles have shown great promise in the targeted delivery of drugs to cells, but researchers at the University of Georgia have refined the drug delivery process further by using nanoparticles to deliver drugs to a specific organelle within cells.

21 Sep 2012